Evidence map›Paper›PMID 31828215›Full record

ArticleEndoscopy international open2019

Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB.

Hidemasa Kawabata, Yuki Miyazawa, Hiroki Sato, Tetsuhiro Okada, Akihiro Hayashi, Takuya Iwama, Shugo Fujibayashi, Takuma Goto, Junpei Sasajima, Shuhei Takauji and 8 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Endoscopy international open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Hidemasa KawabataDepartment of Medicine.
Yuki MiyazawaDepartment of Medicine.
Hiroki SatoDepartment of Medicine.
Tetsuhiro OkadaDepartment of Medicine.
Akihiro HayashiDepartment of Medicine.
Takuya IwamaDepartment of Medicine.
Shugo FujibayashiDepartment of Medicine.
Takuma GotoDepartment of Medicine.
Junpei SasajimaDepartment of Medicine.
Shuhei TakaujiDepartment of Medicine.
Mikihiro FujiyaDepartment of Medicine.
Yoshihiro TorimotoOncology Center.
Mishie TaninoDepartment of Surgical Pathology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Yuko OmoriDepartment of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yusuke OnoDepartment of Medicine.
Hidenori KarasakiInstitute of Biomedical Research, Sapporo-Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan.
Yusuke MizukamiDepartment of Medicine.
Toshikatsu OkumuraDepartment of Medicine.
Sapporo Higashi Tokushukai Hospital · JPMolecular Oncology (United States) · USAsahikawa Medical University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31828215
PMCPMC6904237
OpenAlexW2996346682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.